Continuous glucose monitoring in the GRADE trial shows that incretin-based drugs such as sitagliptin and liraglutide produce the most stable glycemic profiles and show the lowest hypoglycemia risk.

World Experiences Switching Patients to CGM Devices,' the experts explore the following question: 1. What is a patient case ...

Please provide your email address to receive an email when new articles are posted on . CGM use may alleviate barriers for women with type 1, type 2 or gestational diabetes. CGM may improve neonatal ...

Manage diabetes and not CGM interruptions with the new Eversense 365 CGM system – the only One Year CGM that is designed to help minimize device frustrations Ascensia launches the world’s first One ...

Alphaliner says CMA CGM is testing a wider return to the Red Sea, adding three more services on a trial basis via ...

SAN FRANCISCO – Jake Leach, the new CEO of glucose-monitoring company Dexcom, sat down with MobiHealthNews outside the JPM Healthcare Conference to discuss his vision for the company and how AI and ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Data derived from continuous glucose monitoring (CGM) devices can help guide nutrition management and insulin dosing in people with type 2 diabetes (T2D) in primary care settings. At the Advanced ...

This diabetes technology offers a continuous stream of data to show a more complete picture of your blood sugars over time. This is different from a fingerstick meter that only represents that moment.

Toby Bloomberg recently published a Q&A with Bill Neal, the "Godfather of Marketing Research," about the role of consumer-generated media in market research. Bill is an accomplished researcher, and ...